Synthon Advances First ADC To Clinic, Adding Specialty Pharma To Generics Expertise
This article was originally published in The Pink Sheet Daily
Executive Summary
The Dutch company is the latest generics firm aiming to enter the specialty pharma sector, and is up-and-running with its own pipeline of anticancer and autoimmune drugs.